LSC is a privately - held biotechnology company that develop, manufacture and commercialize dermal, trans-dermal and sub-dermal delivery technologies for use in cosmetic skin care products, prescription dermatological, and other pharmaceutical products. LSC’s patented flagship technology, Hydroxysomes®, is a sustainable non-liposome- and non-polymer-based micro-carrier platform dermal delivery system made up of inorganic particles from natural mines. The particles are 100% bio-degradable and its phosphate and calcium functional groups are recognized as micronutrients and metabolized by the skin. Innovative Hydroxysomes bioactives, include cosmetic stable actives such as calcium, resveratrol, retinal, adenosine, LHA and others. They allow higher efficiency, improved stability, sustained release. They are easy to formulate with and offer a damage-free/non-invasive increased skin penetration without use of any penetration enhancers.